Seamless Adoption of Mid-Study Protocol Change
An emerging biotech firm conducting a complex Phase III trial was facing a protocol change that would render the Interactive Response Technology (IRT) system for Part II of the study unusable. This case study reveals the innovative solution and IRT platform that allowed the firm to meet their goals without interruption or patients lost.
You’ll discover:
- Cost-effective solutions for procuring and dispensing medication
- Risks associated with amending the protocol and then employing sound solutions
- The benefits of a total view over distribution logistics
Free Instant Access
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to [email protected]. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.
Utilize Almac Clinical Technologies’ expert team to ensure that your study objectives are fully understood and accurately implemented – submit an IRT request here for immediate review.
